Korean drug price reform will hurt pharmaceutical sector

Korea's pharmaceutical sector could lose up to 3 trillion won if the government’s drug price reform plan takes into effect this October, according to the Korea Pharmaceutical Manufacturers Association.

The estimated losses are based on an assumption that if the controversial incentive system for healthcare facilities is to be made available, the local pharmaceutical segment is expected to su...